CD19 and B-cell chronic lymphocytic leukemia: Based on immunophenotypic studies, CLL is described as a progressive accumulation of monoclonal B lymphocytes with positive expression of CD5, CD19, and CD23 antigens in the peripheral blood, bone marrow, lymph nodes, and extra-nodal organs [1,3,4,5].